1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Xyntha Solofuse-Drug Insights,2014

Xyntha Solofuse-Drug Insights,2014

  • June 2014
  • -
  • Delve Insight

DelveInsight’s pharmaceuticals report, “Xyntha Solofuse - Drug Insights, 2014” provides Xyntha Solofuse marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed clinical assessment of the drug, patent details, route of synthesis, competitive landscape, and analysis of sales performance during the forecast period (2011-2015). The report also includes SWOT analysis for the drug. This report is built using data and information sourced from DelveInsight proprietary databases, primary and secondary research using Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by DelveInsight team of industry experts.

Data Sources
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated drug.

Scope
- A review of the Xyntha Solofuse based on information derived from company and industry-specific sources
- Coverage of the Marketed data of the Xyntha Solofuse on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification
- Coverage of the United States Drug Master File (US DMF), Active Substance Master File/EU DMF and API Manufactures in China & India for Schizophrenia drugs with location details
- Patent Expiry Timeline and Exclusivity Details
- Route of Synthesis of the API
- Global Forecasted Sales Figure from 2011-2015
- Qualitative and quantitative assessment of market space
- SWOT Analysis

Reasons to buy
- Evaluate the marketing status and exclusivity details of Xyntha Solofuse to exploit opportunities for generic drug development opportunities.
- Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Xyntha Solofuse.
- API intelligence over Xyntha Solofuse and gaining primary intelligence over Active Ingredients manufacturers across the globe.
- Understanding the chemical route of synthesis of Xyntha Solofuse.
- Uncovering opportunities in the rapidly growing the US market
- Stay ahead of competition by understanding the changing competitive landscape
- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
- Make more informed business decisions from insightful and in-depth analysis of the drug’s performance
- Obtain sales forecast for currently marketed drug for 2011-2015

Table Of Contents

Xyntha Solofuse-Drug Insights,2014
- Drug Overview
- Global Sales Assessment
- Product Description
- Mechanism of Action
- Pharmacodynamic Properties
- Pharmacokinetic Properties
- Marketed Details for the United States
- Marketed Details for the Europe
- Patent Information
- Patent and Exclusivity Expiry Assessment United States (US)
- Patent Numbers and Expiry Details
- Patent Details
- Route of Synthesis
- Global API Manufacturers Assessment
- The United States Drug Master File (US DMF)
- The Europe Drug Master File (EUDMF)/Active Substance Master File (ASMF)
- The Active Pharmaceutical Ingredient (API) Manufacturers in the ASIA Region
- The Active Pharmaceutical Ingredient (API) Manufacturers by the United States Drug Master (DMF) File Status
- The Active Pharmaceutical Ingredient (API) Manufacturers by Region
- The Active Pharmaceutical Ingredient (API) Manufacturers by Location/Countries
- Generic Players
- The Pipeline Coverage
- Clinical Trials Information
- Clinical Trials by Zone
- Company Profile
- Summary
- Company Financials
- SWOT Analysis
- References
- Appendix
- Methodology
- About DelveInsight
- Contact Us
- Disclaimer


List of Tables
- Xyntha Solofuse, Market, Global Sales (in USD), 2014
- Xyntha Solofuse, Description
- Xyntha Solofuse, Marketed Details the United States (US)
- Xyntha Solofuse, Marketed Details the Europe (EU)
- Xyntha Solofuse, Patent/Exclusivity Expiry (Year), 2014
- Xyntha Solofuse, Patent Number Specific Patent Expiry (Year), 2014
- Xyntha Solofuse, Patent Details
- Xyntha Solofuse, Route of Synthesis
- Xyntha Solofuse, the United States Drug Master File (US DMF), 2014
- Xyntha Solofuse, the Europe Drug Master File (EUDMF)/Active Substance Master File (ASMF), 2014
- Xyntha Solofuse, the API Manufacturers, China, 2014
- Xyntha Solofuse, the API Manufacturers, India, 2014
- Xyntha Solofuse, the API Manufacturers by the US DMF Status, 2014
- Xyntha Solofuse, the API Manufacturers by Region, 2014
- Xyntha Solofuse, the API Manufacturers by Location/Countries, 2014
- Xyntha Solofuse, Generic Players, 2014
- Xyntha Solofuse, Pipeline Drug Details, 2014
- Xyntha Solofuse, Clinical Trials, 2014
- Xyntha Solofuse, Clinical Trials by Zone, 2014
- Company Overview, 2014
- Xyntha Solofuse, SWOT Analysis, 2014
- Phase III Pipeline Therapeutics, 2014

List of Figures
- Xyntha Solofuse, Market, Global Sales (in million USD), 2014
- Xyntha Solofuse, Global Sales % Change, 2014
- Xyntha Solofuse, Patent/Exclusivity Expiry (Year), 2014
- Xyntha Solofuse, Patent Number Specific Patent Expiry (Year), 2014
- Xyntha Solofuse, Route of synthesis
- Xyntha Solofuse, the API Manufacturers by the US DMF Status (%), 2014
- Xyntha Solofuse, the API Manufacturers by Region, 2014
- Xyntha Solofuse, the API Manufacturers by Location/Countries, 2014
- Xyntha Solofuse, Generic Players, 2014
- Xyntha Solofuse, Clinical Trials by Zone (%), 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Europe Cancer Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Spain, UK

2016 Europe Cancer Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Spain, UK

  • $ 12800
  • Industry report
  • September 2016
  • by Venture Planning Group

Complete report $19,700.  DataPack (test volumes, sales forecasts, supplier shares) $12,800. VPGMarketResearch’s new report is a study of the major business opportunities emerging in the European cance ...

R&D Drug Pipeline Database: 1-Year Subscription

R&D Drug Pipeline Database: 1-Year Subscription

  • $ 6600
  • Industry report
  • November 2016
  • by La Merie Publishing

R&D Drug Pipeline Database: 1-Year Subscription Subscription to La Merie Publishing’s proprietary R&D Drug Pieline Database provides 24/7 online access to information about more than 21,000 project entries ...

Cancer Vaccines: Technologies and Global Markets

Cancer Vaccines: Technologies and Global Markets

  • $ 6650
  • Industry report
  • November 2016
  • by BCC Research

This cancer vaccines report by BCC Research explores present and future strategies within the market which includes prophylactic vaccines and therapeutic vaccines. Use this report to: - Analyze the global ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.